1397205989032607755

#DYK GDA-201, an innate Natural killer (NK) cell immunotherapy, is one of Gamida Cell’s potential treatments that is currently being evaluated in a Phase 1 clinical study? More here: https://t.co/5HaGv5EiyC https://t.co/9Q9tZQyb21

Send us a message